New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
Bladder Cancer Canada is the only national patient advocacy organization for the over 80,000 Canadians living with bladder cancer. In addition to its patient support mission, targeted research funding is an important organizational priority.
Myeloma Canada is the only national charitable patient organization created by, and for, Canadians impacted by myeloma. A patient-driven approach to research prioritization guides it research funding decision-making.
We look forward to learning about and from our newest members!
Outstanding Contributions to the Canadian Cancer Research Community
The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on cancer research and the cancer research community. We are pleased to announce the five recipients of the 2023 Awards. In alphabetical order,... Read More »
The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on cancer research and the cancer research community. We are pleased to announce the five recipients of the 2023 Awards. In alphabetical order,... Read More »
Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »